These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 32783303)

  • 1. Enhanced PD-L1 expression on tumor cells in primary cutaneous large T-cell lymphoma with CD30 expression as classic Hodgkin lymphoma mimics: A report of lymph node lesions of two cases.
    Takahashi E; Tsuchida T; Baba S; Tsuzuki T; Shimauchi T; Tokura Y; Tamada Y; Nakamura S
    Pathol Int; 2020 Oct; 70(10):804-811. PubMed ID: 32783303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment.
    Dumitru AV; Țăpoi DA; Halcu G; Munteanu O; Dumitrascu DI; Ceaușu MC; Gheorghișan-Gălățeanu AA
    Cells; 2023 Jul; 12(13):. PubMed ID: 37443818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti-CD30 CAR T-cell therapy.
    Marques-Piubelli ML; Kim DH; Medeiros LJ; Lu W; Khan K; Gomez-Bolanos LI; Rodriguez S; Parra ER; Ok CY; Aradhya A; Solis LM; Nieto YL; Steiner R; Ahmed S; Vega F
    Histopathology; 2023 Jul; 83(1):143-148. PubMed ID: 36994939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of PD-1/PD-L1 in peripheral blood and tumor tissues of patients with classical Hodgkin's lymphoma.
    Feng X; Luo X; Yang Y; Fan Y; Ye Q
    Medicine (Baltimore); 2023 Nov; 102(44):e35757. PubMed ID: 37933048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-L1 immunohistochemistry assay optimization to provide more comprehensive pathological information in classic Hodgkin lymphoma.
    Shi Y; Mi L; Lai Y; Zhao M; Jia L; Du T; Song Y; Li X
    J Hematop; 2023 Mar; 16(1):7-16. PubMed ID: 38175373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological features of primary mucosal CD30-positive T-cell lymphoproliferative disorders].
    Dong N; Zhang LN; Zheng YY; Zhang YL; Zhou XG; Xie JL
    Zhonghua Bing Li Xue Za Zhi; 2024 Jul; 53(7):667-671. PubMed ID: 38955696
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy.
    Ruggeri E; Frezzato F; Mouawad N; Pizzi M; Scarmozzino F; Capasso G; Trimarco V; Quotti Tubi L; Cellini A; Cavarretta CA; Ruocco V; Serafin A; Angotzi F; Danesin N; Manni S; Facco M; Piazza F; Trentin L; Visentin A
    Front Immunol; 2024; 15():1393485. PubMed ID: 38807597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classic Hodgkin lymphoma with marked granulomatous reaction: A clinicopathologic study of 20 cases.
    Xu J; Li S; Yin CC; Patel KP; Tang G; Wang W; Miranda RN; Garces S; Tang Z; Lin P; Medeiros LJ
    Hum Pathol; 2023 Apr; 134():114-123. PubMed ID: 36584716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case of Classic Hodgkin Lymphoma Involving the Uterine Cervix Presenting As Vaginal Spotting.
    Mohammed Saeed D; Patel P; Guzman G; Ni H
    Cureus; 2020 Jun; 12(6):e8889. PubMed ID: 32742856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing assessment of CD30 expression in Hodgkin lymphoma by controlling for low expression.
    Sarwar S; Tome ME; Billheimer D; Spier C; Smith CL; Persky D; Schmelz M
    Histol Histopathol; 2024 Mar; 39(3):319-331. PubMed ID: 37377225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin Reed-Sternberg-Like Cells in Non-Hodgkin Lymphoma.
    Parente P; Zanelli M; Sanguedolce F; Mastracci L; Graziano P
    Diagnostics (Basel); 2020 Nov; 10(12):. PubMed ID: 33261174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole slide imaging of tumour microenvironment in classical Hodgkin's lymphoma: development of a clinical prediction model based on programmed death-ligand 1 and tumorous Reed-Sternberg cells.
    Santisteban Espejo A; Bernal-Florindo I; Montero-Pavon P; Perez-Requena J; Atienza-Cuevas L; Villalba-Fernandez A; Garcia-Rojo M
    J Clin Pathol; 2023 Nov; ():. PubMed ID: 37977655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular techniques drive cutting edge advancements in management of cutaneous T cell lymphoma.
    Lefebvre MN; Borcherding N; Reis RJ; Mou E; Liu V; Jabbari A
    Front Immunol; 2023; 14():1228563. PubMed ID: 37654486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of Hodgkin lymphoma in the modern era.
    Wang HW; Balakrishna JP; Pittaluga S; Jaffe ES
    Br J Haematol; 2019 Jan; 184(1):45-59. PubMed ID: 30407610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression Patterns of GATA3 in Classical Hodgkin Lymphoma: A Clinico-Pathological Study.
    Papoudou-Bai A; Koumpis E; Karpathiou G; Hatzimichael E; Kanavaros P
    Diseases; 2024 Feb; 12(3):. PubMed ID: 38534975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma.
    van Bladel DAG; Stevens WBC; Kroeze LI; de Groen RAL; de Groot FA; van der Last-Kempkes JLM; Berendsen MR; Rijntjes J; Luijks JACW; Bonzheim I; van der Spek E; Plattel WJ; Pruijt JFM; de Jonge-Peeters SDPWM; Velders GA; Lensen C; van Bladel ER; Federmann B; Hoevenaars BM; Pastorczak A; van der Werff Ten Bosch J; Vermaat JSP; Nooijen PTGA; Hebeda KM; Fend F; Diepstra A; van Krieken JHJM; Groenen PJTA; van den Brand M; Scheijen B
    Blood Adv; 2023 Oct; 7(19):5911-5924. PubMed ID: 37552109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difficulty differentiating primary mediastinal classical Hodgkin lymphoma from inflammatory myofibroblastic tumor: A case report.
    Akata K; Yamasaki K; Chiba Y; Kawaguchi T; Dosaka H; Morimoto T; Higashi Y; Nishida C; Shimajiri S; Yatera K
    Thorac Cancer; 2024 Feb; 15(5):410-414. PubMed ID: 38158872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Checkpoint inhibition enhances cell contacts between CD4+ T cells and Hodgkin-Reed-Sternberg cells of classic Hodgkin lymphoma.
    Yadigaroglu K; Scharf S; Gretser S; Schäfer H; Deli ASS; Loth AG; Yegoryan H; Schmitz R; Donnadieu E; Hansmann ML; Hartmann S
    Haematologica; 2024 May; ():. PubMed ID: 38779721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal T follicular helper cell lymphoma with aberrant CD20 expression and monoclonal TCR, IG rearrangements secondary to Classical Hodgkin Lymphoma: a case report.
    Zhu N; Pan Y; Song L; Li N; Sui X; Yang P; Liu X; Zhang L; Yu G
    Med Mol Morphol; 2024 Jul; ():. PubMed ID: 39012522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma.
    Stewart BJ; Fergie M; Young MD; Jones C; Sachdeva A; Blain A; Bacon CM; Rand V; Ferdinand JR; James KR; Mahbubani KT; Hook L; Jonas N; Coleman N; Saeb-Parsy K; Collin M; Clatworthy MR; Behjati S; Carey CD
    Blood; 2023 May; 141(19):2343-2358. PubMed ID: 36758207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.